Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modified radioimmunoassay for pimozide

G Peinhardt1, M Chavarria Perez

  • 1Institut für Pharmazeutische Chemie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany.

Die Pharmazie
|November 5, 1997
PubMed
Summary

A new tritium-labeled pimozide derivative offers a more convenient tracer for radioimmunoassay (RIA). This optimized synthesis improves immunogen preparation for RIA analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Glycine determination according to the European Pharmacopoeia].

Die Pharmazie·2004
Same author

Microionization constants: novel approach for the determination of the zwitterionic equilibrium of hydroxyphenylalkylamines by photometric titration.

International journal of pharmaceutics·2001
Same author

Radioimmunoassay for the determination of pholedrine.

Die Pharmazie·1998
Same author

Phospholipase A2 inhibition by alkylbenzoylacrylic acids.

Biochemical pharmacology·1992
Same author

[The stability of hydrochlorothiazide and cyclopenthiazide in various dosage forms. 3. Stability of hydrochlorothiazide injection solutions].

Die Pharmazie·1986
Same author

[Butaperazine blood level determination by radioimmunoassay following oral application of Tyrylen drug forms].

Die Pharmazie·1986

Area of Science:

  • Analytical Chemistry
  • Biochemistry

Background:

  • Radioimmunoassay (RIA) is a common method for quantifying substances.
  • Tritium-labeled pimozide is a key tracer in RIA for pimozide detection.
  • Current methods for preparing tritium-labeled pimozide may lack convenience.

Purpose of the Study:

  • To develop a more conveniently prepared tritium-labeled pimozide derivative.
  • To optimize the synthesis of the immunogen for RIA.

Main Methods:

  • Synthesis of a novel tritium-labeled pimozide derivative.
  • Optimization of the conjugation rate during immunogen synthesis.

Main Results:

  • A new, conveniently prepared tritium-labeled pimozide derivative was successfully synthesized.
  • The conjugation rate in immunogen synthesis was optimized to 12-13.

Conclusions:

  • The novel tritium-labeled pimozide derivative serves as a viable and more convenient substitute tracer for RIA.
  • Optimized immunogen synthesis enhances the efficiency of RIA assay development.

Related Experiment Videos